Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences

[1]  L. Cattel,et al.  A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions. , 2001, Farmaco.

[2]  J. Garcia-conde,et al.  Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trial. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  I. Smith,et al.  Vinorelbine – a clinical review , 2000, British Journal of Cancer.

[4]  S. Allerheiligen,et al.  Preclinical, pharmacologic, and phase I studies of gemcitabine. , 1997, Seminars in oncology.

[5]  D. Crivellari,et al.  Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer. , 1997, European journal of cancer.

[6]  R. Sorio,et al.  Sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of vinorelbine plasma concentrations. , 1996, Journal of chromatography. B, Biomedical applications.

[7]  S. Anliker,et al.  Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection. , 1995, Journal of chromatography. B, Biomedical applications.

[8]  J. Barbet,et al.  Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine). , 1987, Cancer research.

[9]  Poirier Jm.  Sensitive high performance liquid chromatographic analysis of ethmozin in plasma. , 1985 .

[10]  C Revillard,et al.  [Clinical pharmacokinetics]. , 1976, Schweizerische medizinische Wochenschrift.